Various Adverse Effects and Behaviors Associated with Sildenafil; Another Case of Glycemic Control Problems Associated with Fluoroquinolone Therapy; The First Case of Pure White Cell Aplasia in a Patient Treated with Imipenem–Cilastatin; High-Output Heart Failure Associated with Anagrelide; Renal Dysfunction Attributed to Oral Acyclovir Therapy; Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy – Reiterating the Importance of Reporting Adverse Events; A Final Note on Medication Adherence

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.